• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻腔内给予胰岛素通过 Akt/GSK3β 信号通路改善帕金森病大鼠模型的认知功能障碍。

Intranasal insulin ameliorates cognitive impairment in a rat model of Parkinson's disease through Akt/GSK3β signaling pathway.

机构信息

Department of Neurology, Affiliated Hospital of Qingdao University, Qingdao, China.

Department of Neurology, Affiliated Hospital of Qingdao University, Qingdao, China.

出版信息

Life Sci. 2020 Oct 15;259:118159. doi: 10.1016/j.lfs.2020.118159. Epub 2020 Aug 4.

DOI:10.1016/j.lfs.2020.118159
PMID:32763288
Abstract

AIMS

Parkinson's disease dementia (PDD) is one of the most common non-motor symptoms of advanced Parkinson's disease (PD). This study aimed to determine whether intranasal insulin has protective effects on cognition in the rat PD model induced by 6-hydroxylase dopamine (6-OHDA) through the insulin signaling pathway.

MATERIALS AND METHODS

The rats were given intranasal insulin administration for six weeks after unilateral medial forebrain bundle (MFB) injection of 6-OHDA. Then a series of cognitive-behavioral tests, immunofluorescence, and immunoblotting was performed on the rats.

KEY FINDINGS

The results demonstrated that the injection of 6-OHDA in the unilateral MFB damaged working memory and long-term habituation of rats in the T-maze rewarded alternation test and hole-board test. Besides, rats with unilateral 6-OHDA injury performed poorly in terms of escape latency and average speed during the hidden platform training phase rather than in the probe trial of the Morris Water Maze (MWM) test. Immunofluorescence results showed that unilateral 6-OHDA injury in MFB led to the massive death of ipsilateral-substantia nigra (SN) tyrosine hydroxylase (TH)-positive neurons. Western blot results further indicated that 6-OHDA-induced necrosis of ipsilateral-SN dopaminergic neurons reduced the levels of p-Akt (Ser473) and p-GSK3β (Ser9) in the ipsilateral-hippocampus.

SIGNIFICANCE

These findings provide a solid evidence base for the relationship between PD cognitive impairment and insulin signaling pathways.

摘要

目的

帕金森病痴呆(PDD)是晚期帕金森病(PD)最常见的非运动症状之一。本研究旨在通过胰岛素信号通路确定经鼻内给予胰岛素是否对 6-羟多巴胺(6-OHDA)诱导的大鼠 PD 模型的认知具有保护作用。

材料和方法

在单侧中脑束(MFB)注射 6-OHDA 后,大鼠接受了六周的经鼻内胰岛素给药。然后对大鼠进行了一系列认知行为测试、免疫荧光和免疫印迹。

主要发现

结果表明,单侧 MFB 中的 6-OHDA 注射损伤了大鼠在 T 迷宫奖励交替测试和洞板测试中的工作记忆和长期习惯化。此外,单侧 6-OHDA 损伤的大鼠在隐藏平台训练阶段的逃避潜伏期和平均速度方面表现不佳,而在 Morris 水迷宫(MWM)测试的探针试验中表现不佳。免疫荧光结果显示,MFB 中的单侧 6-OHDA 损伤导致同侧黑质(SN)酪氨酸羟化酶(TH)阳性神经元大量死亡。Western blot 结果进一步表明,6-OHDA 诱导的同侧 SN 多巴胺能神经元坏死降低了同侧海马中 p-Akt(Ser473)和 p-GSK3β(Ser9)的水平。

意义

这些发现为 PD 认知障碍与胰岛素信号通路之间的关系提供了坚实的证据基础。

相似文献

1
Intranasal insulin ameliorates cognitive impairment in a rat model of Parkinson's disease through Akt/GSK3β signaling pathway.鼻腔内给予胰岛素通过 Akt/GSK3β 信号通路改善帕金森病大鼠模型的认知功能障碍。
Life Sci. 2020 Oct 15;259:118159. doi: 10.1016/j.lfs.2020.118159. Epub 2020 Aug 4.
2
Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway.经鼻给予胶质细胞源性神经营养因子通过PI3K/Akt/GSK3β信号通路对帕金森病大鼠模型的神经细胞凋亡具有保护作用。
Neurochem Res. 2017 May;42(5):1366-1374. doi: 10.1007/s11064-017-2184-1. Epub 2017 Feb 28.
3
Brief isoflurane anesthesia regulates striatal AKT-GSK3β signaling and ameliorates motor deficits in a rat model of early-stage Parkinson's disease.短暂异氟烷麻醉调节早期帕金森病大鼠模型纹状体中的AKT-GSK3β信号传导并改善运动功能障碍。
J Neurochem. 2017 Aug;142(3):456-463. doi: 10.1111/jnc.14066. Epub 2017 Jun 14.
4
Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's Disease.鼻腔内给予低剂量胰岛素可改善帕金森病 6-OHDA 大鼠模型的运动功能障碍和多巴胺能神经元死亡。
Neurosci Lett. 2020 Jan 1;714:134567. doi: 10.1016/j.neulet.2019.134567. Epub 2019 Oct 16.
5
Human Basic Fibroblast Growth Factor Inhibits Tau Phosphorylation via the PI3K/Akt-GSK3β Signaling Pathway in a 6-Hydroxydopamine-Induced Model of Parkinson's Disease.人碱性成纤维细胞生长因子通过PI3K/Akt-GSK3β信号通路在6-羟基多巴胺诱导的帕金森病模型中抑制tau蛋白磷酸化。
Neurodegener Dis. 2016;16(5-6):357-69. doi: 10.1159/000445871. Epub 2016 May 27.
6
Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.帕金森病大鼠模型中经鼻给予胶质细胞源性神经营养因子的神经营养和神经保护作用
Neuroscience. 2014 Aug 22;274:11-23. doi: 10.1016/j.neuroscience.2014.05.019. Epub 2014 May 17.
7
PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease.PI3激酶/Akt激活介导雌激素和胰岛素样生长因子-1对帕金森病单侧大鼠模型黑质多巴胺能神经元的神经保护作用。
Dev Neurobiol. 2008 Apr;68(5):632-44. doi: 10.1002/dneu.20609.
8
Central neuropeptide-S treatment improves neurofunctions of 6-OHDA-induced Parkinsonian rats.中枢神经肽 S 治疗可改善 6-OHDA 诱导的帕金森病大鼠的神经功能。
Exp Neurol. 2019 Jul;317:78-86. doi: 10.1016/j.expneurol.2019.02.015. Epub 2019 Feb 27.
9
Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.鼻内注射胰岛素可防止大鼠黑质多巴胺能神经元丢失,并减轻6-羟基多巴胺诱导的运动功能障碍。
Neuroscience. 2016 Mar 24;318:157-65. doi: 10.1016/j.neuroscience.2016.01.020. Epub 2016 Jan 14.
10
Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson's disease: linking to Akt/GSK3β signaling pathway.尿酸对帕金森病 6-OHDA 损伤大鼠模型的神经保护作用:与 Akt/GSK3β 信号通路的关联。
J Neurochem. 2012 Dec;123(5):876-85. doi: 10.1111/jnc.12038. Epub 2012 Oct 25.

引用本文的文献

1
Nose-to-brain drug delivery: from bench to bedside.鼻-脑给药:从实验台到病床边
Transl Neurodegener. 2025 May 19;14(1):23. doi: 10.1186/s40035-025-00481-w.
2
Insulin level regulators may affect cognitive ability caused by motion sickness: an experimental study.胰岛素水平调节剂可能影响晕动病引起的认知能力:一项实验研究。
Metab Brain Dis. 2025 May 16;40(5):203. doi: 10.1007/s11011-025-01630-w.
3
Challenges and Opportunities in Exploring Non-Motor Symptoms in 6-Hydroxydopamine Models of Parkinson's Disease: A Systematic Review.
探索帕金森病6-羟基多巴胺模型中非运动症状的挑战与机遇:一项系统评价
J Neurochem. 2025 Feb;169(2):e70008. doi: 10.1111/jnc.70008.
4
Exceeding the Limits with Nutraceuticals: Looking Towards Parkinson's Disease and Frailty.营养保健品突破极限:展望帕金森病与身体虚弱问题
Int J Mol Sci. 2024 Dec 26;26(1):122. doi: 10.3390/ijms26010122.
5
Antidiabetic drugs in Parkinson's disease.帕金森病中的抗糖尿病药物。
Clin Park Relat Disord. 2024 Jul 18;11:100265. doi: 10.1016/j.prdoa.2024.100265. eCollection 2024.
6
A Comprehensive Approach to Parkinson's Disease: Addressing Its Molecular, Clinical, and Therapeutic Aspects.帕金森病的综合治疗方法:探讨其分子、临床和治疗方面。
Int J Mol Sci. 2024 Jun 29;25(13):7183. doi: 10.3390/ijms25137183.
7
Potential molecular mechanism of exercise reversing insulin resistance and improving neurodegenerative diseases.运动逆转胰岛素抵抗和改善神经退行性疾病的潜在分子机制。
Front Physiol. 2024 May 16;15:1337442. doi: 10.3389/fphys.2024.1337442. eCollection 2024.
8
A nomogram based on neuron-specific enolase and substantia nigra hyperechogenicity for identifying cognitive impairment in Parkinson's disease.基于神经元特异性烯醇化酶和黑质高回声性的列线图用于识别帕金森病中的认知障碍。
Quant Imaging Med Surg. 2024 May 1;14(5):3581-3592. doi: 10.21037/qims-23-1778. Epub 2024 Apr 11.
9
Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue.糖原合酶激酶 3β(GSK-3β)抑制剂在帕金森病中的治疗潜力:探索被忽视的途径。
Mol Neurobiol. 2024 Sep;61(9):7092-7108. doi: 10.1007/s12035-024-04003-z. Epub 2024 Feb 17.
10
Cognitive Impairment in Parkinson's Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches.帕金森病认知障碍:关注新兴药物治疗方法的最新概述。
Medicina (Kaunas). 2023 Oct 1;59(10):1756. doi: 10.3390/medicina59101756.